Pluri : 2023 Annual Report - MarketScreener

CELL-BASED


TECHNOLOGY


PLATFORMS


2023 Annual Report




...

Related Keywords

Israel ,China ,United States ,Japan ,Washington ,Germany ,South Korea ,National Institutes Of Health ,Maryland ,Nevada ,Israeli ,State Of Israel ,America ,Pluristem Gmb , ,Technology Park ,Tnuva Food Industries ,European Union Horizon ,Securities Exchange ,Exchange Commission ,Pluri Biotech Ltd ,Tel Aviv Sourasky Medical Center Ichilov Hospital ,Uniformed Services University Of Health Sciences ,Japan Pharmaceuticals ,Paul Ehrlich Institute ,Israel Ltd ,Devices Agency ,Our Technology ,Dod Armed Forces Radiobiology Research Institute ,Pluri Health ,Foods Ltd ,Us National Institute Of Allergy ,Plurinuva Ltd ,Ministry Of Food ,Clinical Affairs Strategy ,European Medicine Agency ,Data Monitoring Committee ,Us Department Of Defense ,Technology Collaboration The Biologics Field ,Pluri Inc ,Access Program ,Tel Aviv Sourasky Medical Center ,Israel Innovation Authority ,Our Clinical Development Product Candidates ,Drug Administration ,Mark One ,Zip Code ,Securities Exchange Act ,Interactive Data File ,Regulations T ,Sarbanes Oxley Act ,Common Equity ,Related Stockholder Matters ,Issuer Purchases ,Equity Securities ,Financial Condition ,Qualitative Disclosures About Market Risk ,Supplementary Data ,Disagreements With Accountants ,Financial Disclosure ,Regarding Foreign Jurisdictions ,Prevent Inspections ,Executive Officers ,Corporate Governance ,Certain Beneficial Owners ,Related Transactions ,Director Independence ,Accounting Fees ,United States Dollars ,Annual Report ,Private Securities Litigation Reform Act ,European Union ,National Institutes ,Good Manufacturing Practice ,Tnuva Food Tech Incubator ,Limited Partnership ,Chronic Graft ,Host Disease ,Hematopoietic Acute Radiation Syndrome ,Infectious Diseases ,Armed Forces Radiobiology Research Institute ,Uniformed Services University ,Health Sciences ,United Statesa ,Ever After Foods Ltd ,Ever After Foods ,Pluristem Gmbh ,Current Good Manufacturing Practice ,Short Physical Performance Battery ,Hip Abduction Strength ,Acute Respiratory Distress Syndrome ,Investigational New Drug Application ,Expanded Access Program ,Parallel Group Phase ,Intramuscular Injections ,Rutherford Category ,Biologics License Application ,Investigational New Drug ,Ichilov Hospital ,Medical Devices Agency ,Drug Safety ,Food Tech Sector ,After Foods ,Joint Venture Agreement ,Licensed Products ,Closing Date ,Biologics Field ,Far East ,South America ,Markets ,